We have a broad range of high-quality antibodies specific to a number of mammalian species, Birds, Fish and a selection of Pathogens.
Through collaborative studies, a large panel of antibodies have been developed for novel and known biomarker targets. Most antibodies are validated by ELISA, Immunoblotting and immunohistochemistry (IHC) . Antibodies developed twards human targets are validated by IHC on multi-normal and multi-tumour tissue microarray. A significant number of our antibodies has been published in peer-reviewed journals.
Our catalogue include monoclonal and polyclonal antibodies to a wide range of novel and known disease biomarkers: